Food and Drug Administration approvals in phase 3 Cancer clinical trials

Abstract

The majority of FDA approvals are based on data generated from trials analyzing surrogate primary endpoints and trials receiving industry funding. Additional studies are required to understand the complexity of FDA approvals.